2022
DOI: 10.1016/j.technovation.2020.102157
|View full text |Cite
|
Sign up to set email alerts
|

The role of regulators in mitigating uncertainty within the Valley of Death

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
14
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 25 publications
(14 citation statements)
references
References 114 publications
0
14
0
Order By: Relevance
“…18,19 In addition, public policy plays a vital role in supporting the transition to higher TRL. 20 Rapidly developing and deploying CO 2 utilization technologies in a responsible manner requires an accelerated process to translate inventions from research laboratories to the market. Connecting and coordinating communities in academia, business, and government will be essential to address technical, nancial, and societal questions in a responsible and impactful manner.…”
Section: Papermentioning
confidence: 99%
“…18,19 In addition, public policy plays a vital role in supporting the transition to higher TRL. 20 Rapidly developing and deploying CO 2 utilization technologies in a responsible manner requires an accelerated process to translate inventions from research laboratories to the market. Connecting and coordinating communities in academia, business, and government will be essential to address technical, nancial, and societal questions in a responsible and impactful manner.…”
Section: Papermentioning
confidence: 99%
“…Furthermore, these systems require an effective approach to incorporating stakeholders, such as diagnostic test manufacturers and medical professionals, in rulemaking. 9 In the context of pandemics, existing approaches to involving stakeholders may not always be inclusive enough.…”
Section: Preparing For Future Pandemicsmentioning
confidence: 99%
“…Examples of push and pull schemes or models are shown in Rothwell’s diagram. 6 Regulation also plays an important role in the innovative field of medical devices, and as Bonnin Roca and O’Sullivan 7 observe, regulatory agencies in this sector focus on ensuring patient safety rather than promoting innovation. According to Johnson, 8 this affects variables such as costs, quality, and availability in the healthcare system, but also financing options as shown by his observation about the venture capital outflow due to a regulation favouring “sure bets.” 9 …”
Section: Introductionmentioning
confidence: 99%